Abstract:A rapid, simple, and stability-indicating capillary electrophoresis method with UV detection was developed and validated for the assay of risedronate in tablet formulation. During our studies, the effects toward the crucial factors such as the buffer type, concentration and pH, applied voltage, and injection time were investigated. Optimal separation and determination was obtained utilizing 15mM citric acid-disodium hydrogen phosphate (pH 6.0) as running buffer, applied voltage of 20kV, and UV detection at 262nm on an uncoated fused-silica capillary column. Under the optimal conditions, each electrophoretic run was completed within 5min. The optimized method demonstrated good performance concerning selectivity, robustness, linearity (r 2=0.9997), sensitivity (limit of detection: 3 mu g/mL), accuracy (95.3297.43%) and precision (<2.26%). The stability indicating capability of the method was established by enforced degradation studies combined with peak purity assessment using calculated the response ratio of risedronate using peak areas integrated at both 210 and 262nm. As a good alternative to the HPLC method, this approach has been successfully employed for the determination of the commercial available risedronate tablets.

Development and Validation of A Stability Indicating Capillary Electrophoresis Method for the Determination of Risedronate in Tablets